SCHEMBL21387779

SCHEMBL21387779

Cc1cncnc1-c1ccc2[nH]cnc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
QPCT Q16769 5/20 0.38
QPCTL Q9NXS2 3/20 0.38
BRD4 O60885 1/20 0.36
CREBBP Q92793 1/20 0.36
PDK1 Q15118 2/20 0.35
PDK2 Q15119 1/20 0.35
PDK3 Q15120 1/20 0.35
PDK4 Q16654 1/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
APEX1 P27695 1/20 0.34
RECQL P46063 1/20 0.34
BLM P54132 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
TDO2 P48775 1/20 0.34
MMP12 P39900 1/20 0.33
TGFBR1 P36897 1/20 0.33
TBK1 Q9UHD2 2/20 0.33
AURKA O14965 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21565697 0.85 KDM5B (0.37) QPCTQPCTLBRD4CREBBPKDM4E
SCHEMBL21565690 0.82 QPCT (0.36) QPCTQPCTLBRD4CREBBPPDK1
SCHEMBL23123086 0.78 QPCT (0.51) QPCTQPCTLKDM4EALDH1A1MAPT
SCHEMBL21387732 0.78 BRD4 (0.40) QPCTQPCTLBRD4CREBBPKDM4E
SCHEMBL21373612 0.75 BRD4 (0.35) QPCTQPCTLBRD4CREBBPKDM4E
SCHEMBL22901539 0.75 KDM4E (0.40) QPCTQPCTLBRD4CREBBPKDM4E
SCHEMBL6008269 0.75 MAPT (0.50) QPCTQPCTLBRD4CREBBPKDM4E
SCHEMBL31143361 0.75 MAPT (0.50) QPCTQPCTLBRD4CREBBPKDM4E
SCHEMBL2810219 0.74 QPCT (0.41) QPCTQPCTLBRD4CREBBPKDM4E
SCHEMBL16806030 0.74 MAPT (0.41) PDK1PDK2PDK3PDK4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3568133-B1 CELL-PROTECTIVE COMPOUNDS AND THEIR USE ETH ZUERICH (CH) 2023-12-13 EP disclosed
EP-3543231-A1 COMPOUNDS FOR TREATING CNS- AND NEURODEGENERATIVE DISEASES ETH Zurich (CH) 2019-09-25 EP disclosed